Conference Call with Advanced Enzyme Technologies Management and Analysts on Q1FY23 Performance and Outlook. Listen to the full earnings transcript.
Conference Call with Advanced Enzyme Technologies Management and Analysts on Q4FY22 Performance and Outlook. Listen to the full earnings transcript.
Biotechnology firm Advanced Enzyme Technologies declares Q4FY22 result: Revenue from operations on consolidated basis decreased to Rs 1,317 million in the Q4 FY22 from Rs 1,332 million in the Q4 FY21, showcasing a slight decline of 01%. Consolidated EBITDA during Q4 FY22 stands at Rs 403 million as compared to Rs 550 million during Q4 FY21, decrease of 27%. Profit before tax stands at Rs 340 million during Q4 FY22 as against Rs 475 million in Q4 FY22, decline of 29%. Profit after tax de-grew by 25% and stands at Rs 253 million during Q4 FY22 as compared to Rs 336 million during the Q4 FY21. EBITDA margin stands at 31%, PBT margin stands at 26% and PAT margin stands at 19% during the quarter. Financial costs stood at Rs 7 million during Q4 FY22 as against Rs 4 million in Q4 FY21 Depreciation and Amortization charge for the Q4 FY22 is Rs 91 million as compared to Rs 87 million in the same quarter previous year. Earnings Per Share during Q4 FY22 stands at Rs 2.19 as compared to Rs 2.81 in Q4 FY21. Revenue from operations on consolidated basis decreased to Rs 1,317 million in the Q4 FY22 from Rs 1,336 million in the Q3 FY22, a slight degrowth of 01%. Consolidated EBITDA during Q4 FY22 stands at Rs 403 million as compared to Rs 491 million during Q3 FY22, decrease of 18%. Profit before tax stands at Rs 340 million during Q4FY22 as against Rs 412 million in Q3 FY22, decline of 18% Profit after tax de-grew by 12% and stands at Rs 253 million during Q4 FY22 as compared to Rs 286 million during the Q3 FY22 Financial costs stood at Rs 7 million during Q4 FY22 as against Rs 3 million during the Q3 FY22 Depreciation and Amortization charge for the Q4 FY22 is Rs 91 million as compared to Rs 88 million in last quarter. Earnings Per Share during Q4 FY22 stands at Rs 2.19 as compared to Rs 2.46 in Q3 FY22. Result PDF